CLINICAL_TRIALS
trial_result
· 2009-10-14
Clinical Trial Update: Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome [Phase 2]
Summary
Phase 2 efficacy and safety study of Aplindore in restless legs syndrome has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurogen Corporation | Conditions: Restless Legs Syndrome | Phase 2 | Status: TERMINATED